Rhumbline Advisers Amneal Pharmaceuticals, Inc. Transaction History

Rhumbline Advisers

$105 Billion
Q2 2024

A detailed history of Rhumbline Advisers transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 233,217 shares of AMRX stock, worth $1.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

233,217

Previous 202,931 14.92%

Holding current value

$1.91 Million

Previous $1.23 Million 20.42%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$5.36 - $7.11 $162,332 - $215,333	30,286 Added 14.92%	233,217 $1.48 Million
Q1 2024 May 09, 2024	SELL	$5.24 - $6.34 $51,666 - $62,512	-9,860 Reduced 4.63%	202,931 $1.23 Million
Q4 2023 Feb 08, 2024	BUY	$3.36 - $6.21 $44,976 - $83,127	13,386 Added 6.71%	212,791 $1.29 Million
Q3 2023 Nov 09, 2023	BUY	$2.76 - $4.59 $1,719 - $2,859	623 Added 0.31%	199,405 $841,000
Q2 2023 Aug 08, 2023	BUY	$1.33 - $3.1 $48,674 - $113,450	36,597 Added 22.56%	198,782 $616,000
Q1 2023 May 11, 2023	BUY	$1.27 - $2.7 $2,123 - $4,514	1,672 Added 1.04%	162,185 $225,000
Q4 2022 Feb 14, 2023	BUY	$1.96 - $2.61 $9,529 - $12,689	4,862 Added 3.12%	160,513 $319,000
Q3 2022 Nov 10, 2022	BUY	$2.02 - $3.62 $18,038 - $32,326	8,930 Added 6.09%	155,651 $314,000
Q2 2022 Aug 11, 2022	BUY	$3.01 - $4.46 $6,438 - $9,539	2,139 Added 1.48%	146,721 $467,000
Q1 2022 May 12, 2022	SELL	$3.9 - $4.89 $53,196 - $66,699	-13,640 Reduced 8.62%	144,582 $603,000
Q4 2021 Feb 10, 2022	BUY	$3.95 - $5.85 $22,467 - $33,274	5,688 Added 3.73%	158,222 $758,000
Q3 2021 Nov 12, 2021	BUY	$4.31 - $5.64 $12,662 - $16,570	2,938 Added 1.96%	152,534 $815,000
Q2 2021 Aug 05, 2021	SELL	$5.12 - $6.82 $23,828 - $31,740	-4,654 Reduced 3.02%	149,596 $766,000
Q1 2021 May 06, 2021	SELL	$4.74 - $7.38 $32,198 - $50,132	-6,793 Reduced 4.22%	154,250 $1.04 Million
Q4 2020 Feb 10, 2021	BUY	$3.95 - $5.42 $28,795 - $39,511	7,290 Added 4.74%	161,043 $736,000
Q3 2020 Nov 12, 2020	SELL	$3.54 - $5.27 $83,154 - $123,792	-23,490 Reduced 13.25%	153,753 $597,000
Q2 2020 Aug 13, 2020	BUY	$2.87 - $5.46 $63,820 - $121,414	22,237 Added 14.35%	177,243 $844,000
Q1 2020 May 06, 2020	BUY	$2.46 - $5.35 $19,648 - $42,730	7,987 Added 5.43%	155,006 $539,000
Q4 2019 Feb 05, 2020	BUY	$2.65 - $5.56 $44,710 - $93,808	16,872 Added 12.96%	147,019 $709,000
Q3 2019 Oct 23, 2019	SELL	$2.29 - $7.1 $1,706 - $5,289	-745 Reduced 0.57%	130,147 $377,000
Q2 2019 Aug 14, 2019	BUY	$6.44 - $14.29 $45,350 - $100,630	7,042 Added 5.69%	130,892 $938,000
Q1 2019 May 01, 2019	SELL	$11.87 - $14.84 $17,330 - $21,666	-1,460 Reduced 1.17%	123,850 $1.76 Million
Q4 2018 Jan 31, 2019	BUY	$13.09 - $21.49 $493,663 - $810,452	37,713 Added 43.05%	125,310 $1.7 Million
Q3 2018 Nov 07, 2018	SELL	$16.4 - $24.27 $93,233 - $137,974	-5,685 Reduced 6.09%	87,597 $1.94 Million
Q2 2018 Aug 06, 2018	BUY	$13.95 - $20.2 $1.3 Million - $1.88 Million	93,282 New	93,282 $1.53 Million

Others Institutions Holding AMRX

# of Institutions

186

Shares Held

137M

Call Options Held

234K

Put Options Held

45.9K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.24B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Amneal Pharmaceuticals, Inc. Transaction History